Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This randomized controlled clinical trial will compare the eradication efficacy of bismuth
quadruple therapy containing clarithromycin+metronidazole, clarithromycin+levofloxacin, or
metronidazole+levofloxacin for Helicobacter pylori first-line treatment in
penicillin-allergic patients. The completion of this trial will expand new therapy for the
treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also
reduce the use of antibiotics.